CompaniesAttenua

Attenua

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

46

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
Today
Hover over trial bars to see details

Recent Trials

NCT03622216Lead Sponsor
A Dose Escalation Study of Bradanicline in Refractory Chronic Cough
PHASE2Completed
46 participants
Started: Nov 5, 2018 · Completed: May 22, 2019
Funding History (1)
D
Apr 26, 2018
Filing
Related Companies
Coda Biotherapeutics
acquired